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        Introduction 
  Studies from model organisms suggest that stalled replication 
forks are stabilized by checkpoint proteins and enzymes that 
contribute to remove the cause of the arrest, for instance sec-
ondary DNA structures or protein  –  DNA complexes, facilitating 
restart of DNA synthesis once the block is relieved (  Branzei and 
Foiani, 2005  ). Alterations in the pathway involved in the recov-
ery of stalled forks cause genome instability and chromosomal 
rearrangements, which are hallmarks of cancer cells and chro-
mosome fragility syndromes ( Myung et al., 2001 ;  Taylor, 2001 ). 
Thus, unveiling the mechanisms of replication fork recovery in 
human cells is of paramount importance. However, little is 
known about the mechanisms of fork recovery both under phys-
iological and pathological conditions in human cells. In this 
regard, cell lines from patients bearing mutations in replication-
related caretaker genes may be of utmost importance as a model 
to investigate how recovery of stalled forks is performed and 
regulated in humans. 
  Werner syndrome (WS) is a rare hereditary disease featuring 
premature aging and enhanced cancer predisposition (  Chen and 
Oshima, 2002  ). WS cells are characterized by reduced replicative 
potential, S-phase defects, chromosome rearrangements, and 
hypersensitivity to replication-perturbing agents, all of which are 
phenotypes directly related to defective handling of stalled forks 
( Franchitto and Pichierri, 2002 ). The protein mutated in WS, WRN, 
belongs to the RecQ class of DNA helicases, a family of enzymes 
that have been largely implicated in the response to perturbed rep-
lication. However, how WRN contributes to the safe handling of 
stalled forks and whether the WS cellular phenotype derives from 
harmful attempts of DNA synthesis recovery is still debated. 
  Consistent with in vitro substrate preference, WRN has 
been proposed to reset reversed forks or other replication inter-
mediates arising after fork stalling, clearing the way to repli-
some progression once the block is removed (  Khakhar et al., 
2003  ). Alternatively, WRN has been implicated in the resolu-
tion of recombination intermediates arising after RAD51-
dependent strand invasion (  Saintigny et al., 2002  ). 
F
ailure to stabilize and properly process stalled repli-
cation forks results in chromosome instability, which 
is a hallmark of cancer cells and several human ge-
netic conditions that are characterized by cancer pre-
disposition. Loss of WRN, a RecQ-like enzyme mutated in 
the cancer-prone disease Werner syndrome (WS), leads 
to rapid accumulation of double-strand breaks (DSBs) and 
proliferating cell nuclear antigen removal from chromatin 
upon DNA replication arrest. Knockdown of the MUS81 
endonuclease in WRN-deﬁ  cient cells completely prevents 
the accumulation of DSBs after fork stalling. Also, MUS81 
knockdown in WS cells results in reduced chromatin re-
cruitment of recombination enzymes, decreased yield of 
sister chromatid exchanges, and reduced survival after 
replication arrest. Thus, we provide novel evidence that 
WRN is required to avoid accumulation of DSBs and fork 
collapse after replication perturbation, and that prompt 
MUS81-dependent generation of DSBs is instrumental for 
recovery from hydroxyurea-mediated replication arrest 
under such pathological conditions.
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survival after hydroxyurea (HU) arrest, which suggests that the 
MUS81 branch is necessary to ensure cellular viability in WS, 
perhaps at the expense of genomic stability. 
  Results 
  WRN prevents accumulation of DSBs 
during DNA synthesis upon 
replication fork stalling 
  Mutations in vertebrate and mammalian genes associated with 
the replication stress response, such as ataxia telangiectasia and 
Rad3  –  related (ATR), determine the appearance of DNA breaks 
in replicating cells (  Cliby et al., 1998  ;   Casper et al., 2002  ; 
  Lomonosov et al., 2003  ;   Trenz et al., 2006  ). Thus, to investigate 
whether loss of WRN could infl  uence DSB formation during 
DNA replication, we inhibited DNA synthesis in wild-type and 
WS cells with HU. We evaluated DSB induction in the whole 
genome using pulsed-fi  eld gel electrophoresis (PFGE) and, at 
the single-cell level, anti  –  phospho-H2AX (   -H2AX)  immuno-
staining. Formation of chromosomal breaks was analyzed early 
after HU-mediated replication arrest and up to 14 h, a time-
point corresponding to accumulation of DSBs in the wild type 
(  Saintigny et al., 2001  ). WRN defi  ciency resulted in enhanced 
accumulation of DSBs under unstressed conditions and at early 
time points after HU treatment. In contrast, wild-type cells ac-
cumulated DSBs only at the 14 h time point (  Fig. 1 A  ). To con-
fi  rm correlation between loss of WRN function and accumulation 
of DSBs after replication arrest in a common genetic back-
ground, we transfected WRN siRNAs in HeLa cells and then 
analyzed DSB formation after HU by PFGE. RNAi effi  ciently 
depleted WRN protein from HeLa cells (see   Fig. 3 B  ), conferring 
  Cells mutated in WRN accumulate DNA breaks if chal-
lenged with replication-perturbing agents, which is indicative 
of incorrect handling of stalled forks (  Pichierri et al., 2001  ). 
However, WS cells are able to recover from DNA synthesis per-
turbation, which suggests that loss of WRN is compensated by 
alternative pathways. 
  MUS81 is a specialized endonuclease that forms a het-
erodimer with EME1 and processes Holliday junctions (HJs) and 
other branched replication or recombination intermediates (  Haber 
and Heyer, 2001  ;   Osman and Whitby, 2007  ). Recently, MUS81 
has been involved in the stabilization of chromatin-bound pro-
liferating cell nuclear antigen (PCNA) and in the cellular recov-
ery upon replication arrest in human cells (  Hanada et al., 2007  ; 
  Shimura et al., 2008  ). In yeasts, mutations of the RecQ helicase 
Sgs1 or Rqh1 are synthetic lethal with mutations in MUS81 
( Boddy et al., 2000 ;  Kaliraman et al., 2001 ;  Mullen et al., 2001 ). 
The observation that mutation in MUS81 reduces viability of 
RecQ-defective yeasts after fork stalling suggested that these 
two proteins may function on common substrates in response to 
replication stress, defi  ning two parallel branches of the replica-
tion fork recovery pathway. 
  Here, we investigated whether WRN defi  ciency might be 
backed up by MUS81-dependent processing of replication in-
termediates formed at stalled forks. 
  We provide evidence that loss of WRN results in fork col-
lapse and that double-strand breaks (DSBs) accumulating in 
WRN-defi  cient cells derive from MUS81-dependent processing. 
We further demonstrate that, in the absence of WRN, MUS81 is 
required for the accumulation in chromatin of both RAD51 and 
RAD52 and for replication recovery. Indeed, depletion of MUS81 
by RNAi in WRN-defi  cient backgrounds signifi  cantly impairs 
  Figure 1.       WRN deﬁ  ciency leads to accumulation of DSBs in 
S phase after replication fork arrest.   (A) Formation of DSBs in 
wild-type and WS ﬁ  broblasts was evaluated by PFGE after 3-, 
6-, and 14-h 2 mM HU treatment. The graph shows quantiﬁ  -
cation of DSBs from three independent experiments. Data are 
presented as mean   ±   SE. (B) Formation of DSBs in HeLa cells 
transfected with control (GFP) or WRN siRNAs was evaluated 
by PFGE after exposure to 2 mM HU for 3, 6, and 14 h. The 
graph shows quantiﬁ  cation of DSBs from three independent 
experiments. Data are presented as mean   ±   SE. (C) Analysis 
of DSB accumulation by anti  –      -H2AX immunoﬂ  uorescence. 
Wild-type, WS, and HeLa cells transfected with control (GFP) 
or WRN siRNAs were treated with 2 mM HU for the indicated 
times. Images show wild-type and WS cells treated with 2 mM 
HU for 6 h. Graphs show the percentage of     -H2AX  –  positive 
nuclei in wild-type, WS (left), or HeLa cells transfected with 
control (GFP) or WRN siRNAs (right). Data are presented 
as mean   ±   SE from three independent experiments. (D) Co-
localization of DSBs and replicating DNA. Wild-type and WS 
ﬁ  broblasts were labeled with BrdU for 30 min before addition 
of 2 mM HU for 6 h. Replicating DNA was visualized using 
anti-BrdU antibodies, whereas DSBs were labeled with anti  –   
  -H2AX. (E) Double immunostaining with the G2-phase marker 
CENP-F and anti  –      -H2AX antibodies. Wild-type and WS cells 
were treated with 2 mM HU for 6 h. Bars, 10   μ  M.     243 ALTERNATIVE FORK RECOVERY IN WS CELLS   • Franchitto et al. 
with a mutation inactivating the Mus81  –  Eme1 complex, which 
indicates that RecQ helicases and the Mus81 endonuclease can 
defi  ne two competing pathways processing branched DNA in-
termediates at stalled replisome (  Boddy et al., 2001  ;   Doe et al., 
2002  ;   Ciccia et al., 2003  ;   Whitby et al., 2003  ;   Cotta-Ramusino 
et al., 2005  ;   Fricke et al., 2005  ). Furthermore, a recent paper 
suggests that the MUS81 function could be required to process 
forks stalled at interstrand DNA crosslink sites forming DSBs 
(  Hanada et al., 2006  ). We investigated whether the genetic in-
teraction observed in yeast was conserved in humans by testing 
the hypothesis that MUS81 could be involved in DSB formation 
in a WRN-defi  cient background. To this end, we used siRNA-
mediated RNAi to down-regulate MUS81 expression in either 
WS or HeLa cells. Under our experimental conditions, RNAi re-
duced MUS81 expression of   >  80% in wild-type, WS, and HeLa 
cells (  Fig. 2, A and B  ), and did not alter cell cycle progression 
(Fig. S3, A and B, available at http://www.jcb.org/cgi/content/
full/jcb.200803173/DC1). 48 h after transfection, replication 
fork arrest was induced with HU, and DSBs were evaluated by 
PFGE. In wild-type fi  broblasts or HeLa cells, MUS81 RNAi 
did not signifi  cantly affect DSB formation after HU treatment, 
at least up to 14 h of replication arrest (  Fig. 2, C and D  ). In 
contrast, depletion of MUS81 in WRN-defi  cient fi  broblasts or 
concomitant knockdown of WRN and MUS81 in HeLa cells de-
creased the amount of DSBs induced by replication fork stalling 
close to that observed in untreated controls (  Fig. 2, C and D  ). 
Notably, MUS81 down regulation also reduced the spontaneous 
level of DNA breaks observed in WRN-defi  cient cells (  Fig. 2 C  ), 
even though it failed to modulate the breakage in untreated 
WRN RNAi HeLa cells (  Fig. 2 D  ). This apparent discrepancy 
could depend on the enhanced level of MUS81-related DSBs 
accumulating as a consequence of chronic versus acute WRN 
depletion and the PFGE threshold of detection, could be related 
to a more effi  cient MUS81 silencing in WS cells, or could be 
combination of both. However, analysis of the induction of 
    -H2AX foci in HeLa cells treated with WRN or WRN/MUS81 
siRNAs revealed a drastic reduction of    -H2AX  immunostain-
ing in HU-treated cells and untreated samples as well (  Fig. 2 E  ). 
A consistent reduction of DSBs evaluated by   -H2AX immuno-
fluorescence was found also in HU-treated WS cells upon 
transfection with MUS81 siRNAs (unpublished data). It is 
worthwhile to note that accumulation of DSBs after treatment 
with the topoisomerase II  –  poison etoposide was independent of 
the presence of WRN and MUS81 (  Fig. 2 C  ), which suggests 
that MUS81 cleavage is not involved in DSB formation when 
DSBs are formed directly, as occurs after inhibition of topo-
isomerase II by etoposide. 
 In  fi  ssion yeast, activation of MUS81 results in its chroma-
tin accumulation (  Kai et al., 2005  ); thus, we investigated whether 
WRN-defi  cient cells presented enhanced chromatin binding of 
MUS81 after replication fork arrest. To this end, control and WRN 
RNAi-treated HeLa cells were exposed to HU and analyzed for 
the presence of chromatin-bound MUS81 at different time points 
through biochemical fractionation and immunoblotting. 
 In control HeLa cells, the fraction of chromatin-associated 
MUS81 is low and barely increased after replication arrest, 
whereas the amount of chromatin-bound MUS81 was enhanced 
a WS-like phenotype of hypersensitivity to camptothecin (un-
published data). Down-regulation of WRN by RNAi determined 
a time-dependent increase in the accumulation of DSBs in re-
sponse to HU treatment, whereas chromosomal fragmentation 
was barely detectable after transfection with control siRNAs 
(  Fig. 1 B  ). Morphological inspection of HU-treated cultures did 
not provide evidence of cell death, which excludes the possibil-
ity that chromosomal fragmentation derived from the induction 
of apoptosis (unpublished data). 
  Formation of     -H2AX foci is widely used as a marker of 
DSBs and is also thought to correlate with replication-associated 
DSBs (  Ward and Chen, 2001  ). Thus, we performed    -H2AX 
immunostaining in WRN-defi  cient cells as an independent 
approach to evaluate formation of DSBs after HU treatment. 
Although a limited time-dependent increase of   -H2AX – positive 
nuclei was observed in wild-type cells after replication arrest, a 
marked enhancement of     -H2AX foci was detected in WS fi  bro-
blasts after HU treatment (  Fig. 1 C  ). Similarly, WRN RNAi, but 
not transfection with control siRNAs, determined a consistent 
increase in     -H2AX  –  positive nuclei, either in response to HU 
or simply under unperturbed cell growth (  Fig. 1 C  ). To further 
confi  rm our fi  ndings, accumulation of DSBs was also analyzed 
in WS lymphoblasts and their WRN-complemented counter-
parts. Both PFGE and     -H2AX immunostaining revealed a 
marked increase of DSBs depending on the WRN status of the 
cells (Fig. S1, available at http://www.jcb.org/cgi/content/full/
jcb.200803173/DC1). 
  To verify whether DSBs were actually taking place in 
replicating cells, we labeled S-phase wild-type and WS fi  bro-
blasts with a short pulse of BrdU before adding HU for 6 h. 
The occurrence of DSBs in replicating cells was evaluated by 
simultaneous BrdU/    -H2AX immunostaining. The totality of 
    -H2AX  –  positive nuclei was BrdU positive in unstressed and 
HU-treated WS cells (  Fig. 1 D  ). To exclude the possibility that 
DSBs could arise in G2 phase, parallel samples were stained 
with anti  –  centromere protein F (CENP-F) antibodies, which 
are an acknowledged G2 marker (  Rattner et al., 1993  ). Com-
bined     -H2AX and CENP-F immunofl  uorescence showed 
that     -H2AX  –  positive nuclei were always CENP-F negative 
(  Fig. 1 E  ). Accumulation of DSB in WS cells after HU treat-
ment was not paralleled by a defect in the activation of the 
ATR-dependent checkpoint, as shown by comparable levels of 
S345-phosphorylated CHK1 between control and WRN RNAi-
treated cells (Fig. S2, available at http://www.jcb.org/cgi/content/
full/jcb.200803173/DC1). 
  Altogether, our data show that loss of WRN determines an 
enhanced accumulation of DSBs in S-phase cells after replica-
tion inhibition by HU. 
  The MUS81 endonuclease is required to 
induce DSBs in WRN-deﬁ  cient cells after 
replication fork stalling 
  Having demonstrated that WS cells accumulate DSBs after HU-
induced replication arrest, we asked whether those DSBs could 
be the end result of the action of a backup pathway processing 
replication intermediates in the absence of WRN. In yeast, mu-
tations in the RecQ helicases, Sgs1 or Rqh1, are synthetic lethal, JCB • VOLUME 183 • NUMBER 2 • 2008  244
DSBs after replication fork stalling in the absence of WRN pro-
tein. Moreover, the enhanced chromatin association of MUS81 
observed in WRN-defi  cient cells reinforces the hypothesis that 
MUS81 is acting to process replication intermediates, which are 
otherwise targeted by WRN. 
  Dissociation of PCNA from S-phase 
chromatin after replication fork stalling 
occurs in the absence of WRN and is not 
prevented by MUS81 down-regulation 
  Formation of DSBs after replication fork stalling often correlates 
with replication fork collapse, i.e., replisome dissociation from 
the stalled fork (  Branzei and Foiani, 2005  ), a phenomenon that 
can be visualized by monitoring either dissociation of replicative 
polymerases, especially Pol    , or dispersal of the so-called repli-
cation factories (  Montecucco et al., 2001  ;   Cobb et al., 2003  ; 
  Lucca et al., 2004  ). Dispersal of replication factories has been 
visualized at the single-cell level using PCNA immunostaining 
after extraction of the entire non-chromatin-associated fraction. 
To investigate whether, in WS cells, DSB accumulation after HU 
treatment was correlated to fork collapse, we analyzed chromatin 
association of PCNA by Western blotting or biparametric fl  ow 
cytometry (  Scovassi and Prosperi, 2006  ). 
 To validate our approach, we treated cells with 50  μ M etopo-
side, a condition found to determine   >  80% of replisome dis-
assembly as visualized at the single-cell level by PCNA staining 
(  Montecucco et al., 2001  ). Our assays proved to be able to detect 
etoposide-induced replisome disassembly, and, thus, we con-
sider it equivalent to the in situ assay used by   Montecucco     
et al., (2001)   and useful to investigate replisome collapse after 
HU treatment. Analysis of chromatin fractions revealed that 
in WRN RNAi-treated cells under unperturbed conditions and 
increased by   >  50% readily after HU treatment, maintaining sus-
tained levels at later times as well (  Fig. 3  ). Because the fraction 
of S- and G2-phase cells was not different between control and 
WRN RNAi cells (Fig. S4, available at http://www.jcb.org/cgi/
content/full/jcb.200803173/DC1; and not depicted), it is un-
likely that the observed increased chromatin binding of MUS81 
in WRN-depleted cells can be ascribed to a difference in cell 
cycle progression. 
  Altogether, the results of the PFGE analyses and the 
    -H2AX immunostaining indicate that MUS81 is required to form 
  Figure 2.       Accumulation of DSBs after replication arrest observed in the 
absence of WRN depends on the presence of the MUS81 endonuclease.   
(A) MUS81 down-regulation by transfection of MUS81 siRNAs in wild-type 
and WS cells. (B) MUS81 and/or WRN down-regulation by transfection of 
MUS81 and/or WRN siRNAs in HeLa cells was veriﬁ  ed by immunoblotting 
48 h after transfection. (C) Formation of DSBs in wild-type and WS ﬁ  bro-
blasts transfected with MUS81 siRNAs was evaluated by PFGE after 6 h of 
treatment with 2 mM HU or 1   μ  M etoposide (Etop.). Data are presented as 
mean   ±   SE from three independent experiments. (D) Formation of DSBs in 
HeLa cells transfected with control (GFP), MUS81, and/or WRN siRNAs 
and treated with 2 mM HU for the indicated times was evaluated by PFGE. 
Data are presented as mean   ±   SE from three independent experiments. 
(E) Analysis of DSB accumulation by anti  –      -H2AX immunoﬂ  uorescence in 
HeLa cells transfected with control (GFP), MUS81, and/or WRN siRNAs 
and treated with 2 mM HU for 6 h. Representative images are shown. The 
percentage of     -H2AX  –  positive nuclei from three independent experiments 
is shown. Data are presented as mean   ±   SE. Bars, 10   μ  M.     
  Figure 3.       Loss of WRN results in enhanced association of MUS81 with 
chromatin after replication fork stalling.   Levels of chromatin-bound and 
total MUS81 in HeLa cells transfected with control (GFP), WRN, or MUS81 
siRNAs and treated with 2 mM HU for indicated times. ORC2 was used 
as a loading control. The amount of MUS81 in the chromatin fraction is 
expressed as the percentage of the amount in the untreated control nor-
malized against the ORC2 content. (bottom) Total content of MUS81 in 
RNAi-treated HeLa cells was evaluated by Western immunoblotting after 
treatment with 2 mM HU, as in   Fig. 2  .     245 ALTERNATIVE FORK RECOVERY IN WS CELLS   • Franchitto et al. 
HU-induced replication fork stalling did not induce an overt 
dissociation of PCNA from chromatin in wild-type cells, whereas 
WRN defi  ciency determined a much more substantial decrease 
(  Fig. 4 A  ). In contrast, etoposide treatment, which directly causes 
DSBs irrespective of the WRN status of the cells, dropped the 
amount of chromatin-associated PCNA in both wild-type and 
WS cells (  Fig. 4 A  ). Flow cytometry analysis confi  rmed that a 
signifi  cant fraction of PCNA dissociates from chromatin in WS 
cells treated with HU, and evidenced that loss of PCNA oc-
curred specifi  cally in S-phase cells (  Fig. 4 B  ). 
  The requirement of WRN in preventing dissociation of 
PCNA from S-phase chromatin after HU-mediated replication 
fork stalling was also confi  rmed by using RNAi to knock down 
WRN functions in HeLa cells before inducing replication stress. 
As shown in   Fig. 4 C  , WRN RNAi, but not transfection with 
control siRNAs, reduced the amount of PCNA associated with 
chromatin after HU treatment. Having demonstrated that in WS 
cells a MUS81-dependent mechanism produced DSBs after 
replication fork stalling, we asked whether chromatin dissocia-
tion of PCNA was dependent on MUS81. Thus, HeLa cells were 
transfected with WRN siRNAs alone or in combination with 
MUS81 siRNAs, then exposed to HU and fractionated to ana-
lyze subcellular distribution of PCNA by Western blotting.  Fig. 4 D  
shows that PCNA dissociated from chromatin irrespective of 
the presence of MUS81 in WRN-depleted cells. 
  To further demonstrate occurrence of replication fork 
collapse in WRN-defi  cient cells after treatment with HU, we 
measured the effi  ciency of replication recovery using the DNA 
fi  ber assay (  Merrick et al., 2004  ;   Seiler et al., 2007  ). To this 
end, DNA replication sites were pulse-labeled using chloro-
deoxyuridine (CldU) before HU treatment. After replication fork 
stalling, cells were washed and pulse-labeled with iododeoxyuri-
dine (IdU) to visualize the restart of stalled forks (Fig. S5 A, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200803173/DC1). 
CldU-labeled, red tracks represent stalled forks that did not re-
cover DNA replication (i.e., collapsed forks), whereas red tracks 
showing costaining with green IdU-labeled tracks represent 
stalled forks that restore properly DNA replication (Fig. S5, A 
and B). In control RNAi-treated cells, almost all the stalled forks 
recovered upon HU withdrawal, whereas only half of the ongo-
ing forks restarted in WRN RNAi cells (Fig. S5 C). It is worth-
while to note that our data on the collapse of stalled forks by the 
DNA fi  ber assay are in good agreement with PCNA dissocia-
tion from chromatin, obtained by either biochemical fraction-
ation or fl  ow cytometry. The DNA fi  ber assay also confi  rmed 
that fork collapse occurs independently of MUS81 because the 
number of restarting forks was not affected by concomitant de-
pletion of WRN and MUS81 (Fig. S5 D). 
 These results indicate that in WS cells, MUS81-dependent 
DSB accumulation takes place after fork collapse. 
  It has been previously demonstrated that dispersal of rep-
lication foci after etoposide-induced replication fork collapse 
relies on the ATR-dependent checkpoint (  Rossi et al., 2006  ). 
  Figure 4.       Replication arrest induces dispersal of PCNA from S-phase 
chromatin in WRN-deﬁ  cient  cells.   (A) Levels of chromatin-bound PCNA 
in wild-type and WS ﬁ  broblasts treated with 2 mM HU for the indicated 
times or with 50   μ  M etoposide for 6 h (Etop.). H3 histone was used as a 
loading control. The residual amount of PCNA in the chromatin fraction is 
expressed as the percentage of the amount in the untreated control normal-
ized against the H3 histone content. (B) Levels of chromatin-bound PCNA 
in S-phase cells after replication inhibition. Wild-type and WS ﬁ  broblasts 
were exposed to 2 mM HU for the indicated times or to 50   μ  M etoposide 
for 6 h (Etop.), before being processed for biparametric PCNA/DNA ﬂ  ow 
cytometry. Representative cytograms for each condition are presented. The 
values shown represent the ﬂ   uorescence intensity of the PCNA staining 
relative to an S-phase DNA content, expressed as percentage of the un-
treated control. The gates indicate the area considered for the evaluation 
of PCNA ﬂ  uorescence intensity. *, statistically signiﬁ  cant compared with 
the wild type; P   <   0.01 (analysis of variance test). (C) Levels of chromatin-
bound PCNA in HeLa cells transfected with control (GFP) or WRN siRNAs 
and treated with 2 mM HU for the indicated times. H3 histone was used 
as a loading control. The residual amount of PCNA in the chromatin frac-
tion is expressed as the percentage of the amount in the untreated control 
normalized against the H3 histone content. (D) Levels of chromatin-bound 
PCNA in HeLa cells transfected with control (GFP), MUS81, and/or WRN 
siRNAs treated with 2 mM HU for the indicated times. H3 histone was 
 
determined as a loading control. RNAi-labeled samples represent cells 
treated with MUS81 siRNAs; if not otherwise speciﬁ   ed, samples were 
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combination-mediated fork recovery. Indeed, a physical interaction 
between MUS81 and recombination enzymes has been de-
scribed in yeast and mammalian cells (  Interthal and Heyer, 
2000  ;   Hanada et al., 2006  ). To investigate whether DSBs pro-
duced by MUS81 could initiate recombination at forks collapsed 
because of loss of WRN function, we analyzed the accumula-
tion of RAD51 in nuclear foci and its chromatin binding in cells 
depleted of WRN, MUS81, or both by RNAi. Chromatin asso-
ciation of the recombination mediator protein RAD52 was simi-
larly analyzed. Induction of replication arrest with HU induced 
RAD51 accumulation in nuclear foci in a time-dependent man-
ner, and the RAD51 focus-forming activity appeared enhanced 
in WS cells compared with the wild type (  Fig. 5 A  ), which is in 
agreement with our previous studies (  Pichierri et al., 2001  ). 
Consistent fi  ndings were observed in HeLa cells upon depletion 
of WRN by RNAi (  Fig. 5 A  ), which demonstrates that increased 
RAD51 assembly into nuclear foci directly correlates with the 
absence of WRN. Depletion of MUS81 in WS fi  broblasts or 
concomitant knockdown of WRN and MUS81 in HeLa cells 
  Figure 5.       MUS81 down-regulation reduces the assembly in 
nuclear foci and chromatin binding of RAD51 in WS cells after 
replication arrest.   (A) RAD51 assembly in nuclear foci after 
HU treatment. Wild-type and WS ﬁ  broblasts were transfected 
with control or MUS81 siRNAs and exposed to 2 mM HU 
for the indicated times. Representative images of RAD51 as-
sembly in nuclear foci induced by MUS81 RNAi in WS cells 
treated with 2 mM HU for 8 h were shown. The graph shows 
the percentage of RAD51-positive nuclei in wild-type and WS 
cells transfected with control (GFP) or MUS81 siRNAs (left 
graph), or Hela cells transfected with control (GFP), WRN, or 
WRN/MUS81 siRNAs (right graph). Data are means   ±   SE 
from three independent experiments. Bars, 10   μ  M. (B) Levels 
of chromatin-bound and total RAD51 or RAD52 in HeLa cells 
transfected with control (GFP), WRN, and WRN/MUS81 
siRNAs and treated with 2 mM HU (HU) for the indicated 
times. The amount of RAD51 and RAD52 in the chromatin 
fraction was presented as fold increase compared with the 
matched untreated control, normalized against the amount of 
ORC2. The levels of chromatin-associated and total RAD51/
RAD52 proteins observed in MUS81-depleted cells are shown 
as a control.     
Thus, we analyzed whether dissociation of PCNA from chro-
matin in the absence of WRN was related to the ATR-dependent 
checkpoint. To this end, we down-regulated ATR expression by 
RNAi (Fig. S5 A) and examined PCNA chromatin association 
in fractionated extracts from untreated or HU-exposed cells. 
We observed that PCNA dissociation from chromatin was ATR 
dependent after etoposide treatment, irrespective of the pres-
ence of WRN (Fig. S5 B). Likewise, loss of PCNA from chro-
matin observed in the absence of WRN after HU treatment was 
reverted by depletion of ATR by RNAi (Fig. S5 B). 
  Altogether, these results show that loss of WRN deter-
mines collapse of stalled forks in a MUS81-independent but 
ATR-dependent manner. 
  MUS81 is required for replication arrest  –
  dependent recombination observed in the 
absence of WRN 
  The DNA DSBs formed by MUS81 at stalled forks in WRN-
defi  cient cells could be easily used as substrate to initiate re-247 ALTERNATIVE FORK RECOVERY IN WS CELLS   • Franchitto et al. 
and MUS81 operate in two parallel branches of the response to 
replication stress, which suggests that MUS81 down-regulation 
could affect recovery of WRN-defi  cient cells from the HU-
mediated replication arrest. 
  To test this hypothesis, WS fi  broblasts and HeLa cells 
RNA depleted of WRN alone or in combination with MUS81 
were exposed to HU for 16 h, then recovered in drug-free me-
dium for different times. 30 min before harvesting, cells were 
pulsed with BrdU to evaluate DNA synthesis. Alternatively, 
wild-type and WS fi  broblasts were transfected with MUS81 
siRNAs and analyzed for the presence of chromosomal damage 
after recovery from HU. Loss of WRN function alone did not 
infl  uence arrest and recovery of DNA synthesis after HU (Figs. 
S3 and S4). In contrast, concomitant MUS81 inhibition by RNAi 
in WS fi  broblasts or in HeLa cells knocked down for WRN sig-
nifi  cantly impaired the ability of HU-arrested cells to resume 
DNA synthesis (  Fig. 7 A  ). Furthermore, MUS81 RNAi in WS 
cells that are recovered from HU-mediated S-phase arrest re-
sulted in the appearance of aberrant metaphases with fuzzy chro-
mosomes and in micronuclei (  Fig. 7 B   and not depicted). 
  To further demonstrate that MUS81 is required for effi  cient 
recovery from replication arrest in a WRN-defi  cient background, 
we abrogated the WRN function alone or in combination with 
MUS81, exposed cells to 14 h of different doses of HU, and com-
pared the clonogenic survival 7 d thereafter. As shown in  Fig. 7 C , 
concomitant down-regulation of WRN and MUS81 determined a 
striking reduction in survival after 14 h of HU-mediated replica-
tion arrest compared with control RNAi and WRN RNAi cells. 
  Altogether, these results show that in WS cells, effi  cient re-
covery from DNA replication arrest and maintenance of cellular 
viability depends on the activation of an alternative pathway of 
replication fork processing requiring the MUS81 protein. 
  Discussion 
  Here, we demonstrate that in the absence of WRN, cells accu-
mulate DSBs upon replication arrest as a consequence of fork 
collapse and activation of a MUS81-dependent pathway. Thus, 
in WRN-defi  cient cells, the MUS81 endonuclease might repre-
sent an alternative pathway to ensure recovery of DNA synthe-
sis by recombination-mediated restart of DNA replication. 
strongly reduced the number of RAD51 foci observed after rep-
lication stalling (  Fig. 5 A  ). Consistent fi  ndings were observed 
by biochemical fractionation analysis. Chromatin binding of 
RAD51 was enhanced in WRN RNAi HeLa cells after HU treat-
ment and was extremely reduced upon concomitant depletion of 
MUS81 (  Fig. 5 B  ). Chromatin binding of the recombination-
mediator protein RAD52 was also enhanced by loss of WRN, 
and when MUS81 was down-regulated, a clear reduction in the 
amount of protein that associates with chromatin was observed 
(  Fig. 5 B  ). Interestingly, both RAD51 and RAD52 were found 
to be more chromatin-associated in WRN-depleted cells even 
under unperturbed conditions, and such enhanced chromatin as-
sociation was reduced after MUS81 knockdown (  Fig. 5 B  ). 
In contrast, the MUS81 down-regulation simply did not reduce 
RAD51 and RAD52 chromatin binding in control HeLa cells or 
wild-type cells (  Fig. 5 B   and not depicted). 
 The  immunofl  uorescence and biochemical fractionation 
experiments indicated that DSBs produced by MUS81 stimulate 
assembly of recombination foci and chromatin association of 
recombination proteins after replication stalling, which sug-
gests that in the absence of WRN, MUS81 can be recruited up-
stream of recombination. To support our hypothesis, we analyzed 
whether the enhanced MUS81 chromatin association observed 
in the absence of WRN was affected by down-regulation of the 
RAD51 protein. We reasoned that if MUS81 actually acts 
before recombination, its association with chromatin should be 
independent from strand invasion. We effi  ciently depleted RAD51 
in HeLa cells, with or without concomitant depletion of WRN 
(Fig. S5 C), and found that MUS81 association with chromatin 
was still enhanced by loss of WRN after RAD51 knockdown 
(Fig. S5 D). Then we evaluated the yield of HU-induced sister 
chromatid exchanges (SCEs) in HeLa cells transfected with 
WRN siRNAs alone or in combination with MUS81 siRNAs. 
Indeed, DSBs formed at stalled forks are thought to be good 
SCE inducers (  Arnaudeau et al., 2001  ;   Lambert and Lopez, 
2001  ). Knockdown of WRN alone increased the yield of HU-
induced SCEs about threefold compared with the cells trans-
fected with control siRNAs, whereas concomitant depletion of 
WRN and MUS81 reduced the level of SCEs back to that ob-
served in untreated cultures (  Fig. 6  ). In contrast, no differential 
induction of SCEs was found after etoposide treatment between 
control and WRN RNAi-treated cells, and no modulation by 
MUS81 was observed (  Fig. 6  ). 
 These  fi  ndings show that loss of WRN promotes the ac-
cumulation of recombination factors in chromatin and stimulates 
SCEs after HU-mediated replication arrest. Moreover, they evi-
denced that increased chromatin binding of recombination 
proteins and elevated recombination are prevented by MUS81 
knockdown, which suggests that MUS81-dependent DSBs created 
at stalled forks are used as a substrate to initiate recombination. 
  In WS cells, MUS81 is required to ensure 
recovery from replication arrest and 
cellular viability 
  In response to HU-mediated replication fork stalling, WRN-
defi  cient cells require MUS81 to produce DSBs and initiate re-
combination. These data are consistent with the notion that WRN 
  Figure 6.       MUS81 depletion affects the recombination-mediated repair of 
stalled forks.   Levels of SCEs induced by HU in HeLa cells transfected with 
control (GFP), WRN, or WRN/MUS81 siRNAs and treated for 16 h with 
2 mM HU (HU) or 300 nM etoposide (Etop.). Error bars represent SEM.     JCB • VOLUME 183 • NUMBER 2 • 2008  248
Synthetic lethality of the yeast recq/mus81 double mutant 
can be prevented by mutations in recombination genes, lead-
ing to a model whereby the common substrate of RecQ he-
licases and MUS81 is formed during recombination-mediated 
replication fork recovery triggered by single-strand gaps (  Fabre 
et al., 2002  ). In contrast, we fi  nd that, in the absence of WRN, 
recombination induced by HU treatment is triggered after 
MUS81 processing of stalled forks, implying that, at least in the 
absence of WRN, MUS81 functions upstream of recombina-
tion. Thus, our data indicate a different behavior of RecQ 
mutant yeasts and human cells mutated in   WRN  . This is not 
surprising because humans have fi   ve RecQ-like helicases 
( Hickson, 2003 ), and many studies evidenced that the functional 
homologue of yeast RecQ helicase is BLM and not WRN 
(  Yamagata et al., 1998  ;   Ira et al., 2003  ;   Wu and Hickson, 2003  ). 
However, at this stage, we cannot exclude the possibility that 
recombination proteins other than RAD51 and RAD52 might 
function at stalled forks to produce an intermediate that is then 
converted into a DSB, which, in turn, recruits RAD52/RAD51 
and initiates recombination. Most likely, it is conceivable that 
  In yeast, the RecQ helicase and MUS81/EME1 are syn-
thetic lethal, and lethality is rescued by introduction of a bacte-
rial resolvase, which suggests that these two proteins act in 
overlapping pathways on a common branched intermediate 
arising at stalled forks, such as an HJ or a regressed fork (  Boddy 
et al., 2000  ;   Mullen et al., 2001  ;   Doe et al., 2002  ). Our fi  ndings 
suggest that such genetic interaction is also maintained in hu-
mans, and that WRN and MUS81 defi  ne two pathways compet-
ing for a common substrate at stalled forks, as suggested by 
their mutually independent subnuclear localization (  Gao et al., 
2003  ). WRN helicase activity displays remarkable substrate 
preference toward forked DNA and several replication interme-
diates that can accumulate at stalled forks, such as D-loops and 
four-way junctions (regressed fork;   Khakhar et al., 2003  ), and 
several of the preferred DNA substrates of WRN are also effi  -
ciently processed by human MUS81 (  Blais et al., 2004  ). Indeed, 
our data support the hypothesis that the two enzymes share 
common substrates and suggest that WRN could disrupt abnormal 
replication intermediates, preventing them from being processed 
by MUS81 and facilitating a safer restart of DNA synthesis. 
  Figure 7.       MUS81 down-regulation reduces the recovery of WS cells from replication arrest, leading to the accumulation of chromosome damage.   
(A) Analysis of the inhibition of DNA synthesis in wild-type and WS cells. Wild-type and WS cells transfected with control (GFP) or MUS81 siRNAs (left) 
and Hela cells transfected with control (GFP), WRN, or WRN/MUS81 siRNAs (right) were treated with 2 mM HU for 14 h, and recovered in drug-free 
medium for the indicated times. The graphs show the percentage of BrdU-positive nuclei compared with the untreated control. Data are means   ±   SE from 
three independent experiments. (B) Analysis of aberrant mitoses induced by replication arrest. Wild-type and WS cells transfected with control (GFP) or 
MUS81 siRNAs were exposed to 2 mM HU for 18 h before being recovered in drug-free medium for the indicated times. Images show mitoses from wild-
type and WS cells in which MUS81 was abrogated. Bars, 20   μ  M. (C) Survival of wild-type, WS, or HeLa cells transfected with the indicated siRNAs in 
response to increasing doses of HU. Data are means   ±   SE from three independent experiments. (D) Schematic model showing the pathways responsible 
for replication fork recovery in wild-type and WS cells.     249 ALTERNATIVE FORK RECOVERY IN WS CELLS   • Franchitto et al. 
  Two characteristic cellular phenotypes of WS cells are 
delayed S phase and asymmetrical elongation of DNA replica-
tion forks (  Takeuchi et al., 1982  ;   Rodriguez-Lopez et al., 2002  ). 
Our observations might contribute to give a mechanistic expla-
nation for these phenotypes. Indeed, recombination engaged at 
collapsed forks would result in additional time to complete 
genome duplication as well as in an accumulation of gross chro-
mosomal rearrangements (  Myung et al., 2001  ), another charac-
teristic feature of WS cells (  Scappaticci et al., 1982  ;   Grigorova 
et al., 2000  ). 
  In conclusion, our results demonstrate a novel role of 
WRN in preventing DSB induction and fork collapse after rep-
lication arrest, and contribute to support a function of WRN as 
a primary factor in the physiological response to stalled replica-
tion. Furthermore, our work uncovers the alternative pathway 
that is essential for the recovery of stalled replication forks in 
WS cells. Unscheduled generation of DSBs by MUS81 in WRN-
defi  cient cells would grant cell viability, perhaps at the expense 
of genomic instability, contributing to the characteristic features 
of this genetic condition. 
  Materials and methods 
  Cell cultures 
  The SV40-transformed wild-type (MRC5SV) and WS ﬁ  broblasts (AG11395; 
Coriell Cell Repositories) were handled as described previously (  Pichierri 
et al., 2004  ). The phenotypically reverted Epstein-Barr virus  –  transformed 
WS lymphoblastoid cell line (WS + WRN) and the parental lymphoblasts 
(AG14426) have been described previously (  Franchitto et al., 2003  ). 
  Treatments and RNAi 
  To evaluate the effect of DNA replication arrest, wild-type and WS cells 
were treated with 2 mM HU for different times or with different doses of HU 
for 6 h. As otherwise indicated, etoposide was used at 50   μ  M for 6 h, a 
condition that has been found to cause an almost complete disassembly of 
the replisome (  Montecucco et al., 2001  ). 
  ATR, MUS81, RAD51, or WRN expression was knocked down by 
transfection with a pool of four siRNAs directed against the coding se-
quence of the genes (SmartPool; Thermo Fisher Scientiﬁ  c). Transfection was 
performed using the HiPerfect reagent (QIAGEN) and 10 nM siRNA pool 
according to the manufacturer’s instructions for adherent cells. Actual down-
regulation was conﬁ  rmed by Western blotting. As a control, an siRNA 
duplex directed against GFP was used (  Pichierri et al., 2004  ). For the sake 
of clarity, data from the mock siRNA control were not included in ﬁ  gures. 
All the RNAi experiments were performed after 48 h from transfection and 
within     72 h after transfection, when maximal inhibition of the expression 
of the target was observed. 
  PFGE 
  DNA fragmentation was analyzed only at different time points after treat-
ment. High molecular weight genomic DNA was prepared in agarose 
blocks from exactly 10 
6   cells as described previously (  Lomonosov et al., 
2003  ) and run on an 0.8% agarose/0.5% Tris/Borate/EDTA gel for 48 h 
on a Gene Navigator apparatus (GE Healthcare) at 70 V with a 20  –  30 min 
ﬁ  eld switch time. DNA fragments from   x  0.2 to 1 Mb appeared as a broad-
ened compression band using our PFGE conditions. 
  Resolved DNA was stained with Sybr green (Invitrogen), and frag-
mented DNA quantitated from images was acquired using a GelDoc sys-
tem (Alpha Innotech) and processed with ImageJ software (National 
Institutes of Health) after color inversion and contrast adjustment. DNA 
breakage was shown as arbitrary units after being normalized against to-
tal DNA contents. Values are given as a comparison against the level of 
DNA breakage of the matched untreated control. Representative images 
from triplicate experiments are shown. 
  Immunoﬂ  uorescence 
  Immunoﬂ  uorescence microscopy was performed on cells grown on cover-
slips. Except for RAD51 immunostaining, which was performed as described 
WRN might perform an antirecombinogenic or a prorecombi-
nogenic function according to the nature of the lesion. Upon 
treatment with agents that directly introduce DSBs or collapse 
the replication fork, WRN would be required to resolve HJs de-
rived from RAD51-dependent strand invasion (  Saintigny et al., 
2002  ). However, our data suggest that, upon replication stalling, 
WRN would act as an antirecombinogenic enzyme. Indeed, loss 
of WRN increased both recruitment of recombination proteins 
and the yield of SCEs after HU treatment. Moreover, abrogation 
of RAD51-dependent recombination does not revert sensitivity 
to HU of WS cells, but rather further reduces viability of WRN-
defi  cient cells upon replication stress (unpublished data). 
 We show that loss of WRN determines unloading of PCNA 
from replicative chromatin after HU treatment, which indicates 
that blocked forks may collapse in WS cells. It has been re-
cently found that in   Schizosaccharomyces pombe ,  recruitment 
of MUS81 to chromatin after replication fork stalling is inhib-
ited, whereas its association with chromatin is strongly stimu-
lated by fork collapse (  Kai et al., 2005  ). We also show that 
human MUS81 does not normally accumulate in chromatin upon 
fork stalling, at least within 14 h of arrest. In contrast, MUS81 
is rapidly recruited to chromatin in the absence of WRN, which 
is consistent with the collapse of stalled forks. These results sup-
port the idea that the MUS81-dependent pathway is not promptly 
activated in human cells by replication arrest after an acute ex-
posure to HU, possibly to avoid formation of dangerous DSBs 
at stalled forks. Accordingly, MUS81-defi  cient cells are not hy-
persensitive to acute HU treatment, although they show height-
ened sensitivity toward agents inducing fork collapse, such as 
cisplatin or mitomycin-C (  McPherson et al., 2004  ;   Dendouga 
et al., 2005  ;   Hanada et al., 2006  ), These data suggest that the care-
taker function of MUS81 is linked to repair of spontaneously 
collapsed rather than blocked replication forks. Interestingly, 
although a recent paper from   Hanada et al., (2007)   confi  rms our 
observations that MUS81 is not activated after short exposure to 
HU, the same work demonstrates that prolonged treatment with 
HU (18  –  24 h) results in the formation of MUS81-dependent 
DSBs. Those DSBs result from the processing of RAD51-
dependent intermediates, and, thus, would represent a different 
mechanism from that disclosed by our data. Probably, in wild-
type cells, recombination initiated from stalled forks cannot be 
terminated properly when replication is still inhibited, and thus, 
intermediates become prone to processing as a sort of   “  adapta-
tion  ”   to chronic replication stress. In contrast, the rapid activa-
tion of the   “  MUS81-dependent branch  ”   of the replication fork 
recovery response, observed in the absence of WRN, would rep-
resent a   “  pathological  ”   pathway adopted by WS cells because of 
the collapse of stalled forks (  Fig. 7 D  ). This behavior resembles 
what is described in yeasts bearing mutations in the DNA poly-
merase      or      (  Murray et al., 1997  ;   Kai et al., 2005  ). It is worth-
while to note that very recently, a recombination-independent 
function of MUS81 has been demonstrated in   S. pombe   yeast 
cells bearing mutations in replication checkpoint factors that 
resulted in replisome destabilization and fork collapse (  Froget 
et al., 2008  ). Similarly, a recombination-independent function 
of MUS81 in response to replication arrest has been demon-
strated in human cells (  Shimura et al., 2008  ). JCB • VOLUME 183 • NUMBER 2 • 2008  250
  Synchronization procedure 
  Cell synchronization was accomplished by a double thymidine block. 
HeLa cells were plated and transfected with siRNAs as described previ-
ously (  Pichierri et al., 2004  ). 8 h after transfection, thymidine was added 
to a ﬁ  nal concentration of 2 mM and cells were incubated for 12 h. Cells 
were then washed twice with PBS and incubated with regular medium for 
14 h before a second incubation with 2 mM thymidine for 12 h. 2 h after 
release from the second block, cells were exposed to 2 mM HU. Cells were 
collected at the indicated times and then processed for cell cycle analysis. 
  Cell cycle analysis by ﬂ  ow cytometry 
  30 min before HU treatment, cultures were pulse-labeled and chased with 
45   μ  M BrdU to analyze progression through the cell cycle of the S-phase 
population. Alternatively, cultures were treated with 2 mM HU for different 
time points and pulsed with 45   μ  M BrdU for 30 min immediately prior to 
harvesting. When indicated, wild-type and WS ﬁ   broblasts were trans-
fected with siRNA pool directed against MUS81 48 h before being ex-
posed to 2 mM HU or 50   μ  M etoposide for the indicated times. 
  Cells were processed for ﬂ  ow cytometry as follows: for each time 
point, 10 
6   cells were collected, and after two washes in PBS, ﬁ  xed in 50% 
cold methanol. Then, cells were exposed to acid denaturation (3 M HCl), 
neutralization (1 M sodium tetraborate), and blocking solution (10% nor-
mal goat serum/PBS). After that, samples were incubated in series with a 
primary anti-BrdU antibody (1:100 in blocking solution) and then with a 
secondary FITC-conjugated antibody (1:50 in blocking solution). Samples 
were resuspended in 20   μ  g/ml propidium iodide before analysis. 
  Evaluation of DNA synthesis 
  For the evaluation of DNA synthesis, cells were exposed to 2 mM HU for 
18 h, washed extensively, and recovered in drug-free medium for different 
time points. 45   μ  M BrdU was added 30 min before harvesting, and BrdU 
incorporation was analyzed as above. At least 500 interphase cells were 
scored to evaluate the percentage of labeled nuclei. Only nuclei displaying 
a distinct replicative pattern of BrdU labeling were considered to be ac-
tively replicating. The percentage of cells undergoing DNA synthesis at 
each time point was calculated as a fraction of the treated cells versus un-
treated controls. 
  For double BrdU/    -H2AX immunostaining, cells were labeled with 
45   μ  M BrdU for 30 min before being treated with 2 mM HU for 6 h. 
    -H2AX immunoﬂ   uorescence was performed as described previously 
(  Pichierri et al., 2001  ), whereas BrdU detection was done after a postﬁ  x-
ation step with a 3:1 methanol/acetic acid solution. 
  Evaluation of mitotic Index by phospho-H3 immunostaining 
  For evaluation of mitotic index, 3   ×   10 
5   cells were plated in 35-mm dishes 
and exposed to 2 mM HU for 3, 6, and 8 h before ﬁ  xation in 2% PFA. After 
permeabilization in 0.5% Triton X-100, cells were blocked in 10% FBS and 
incubated with a 1:1,000 dilution of a polyclonal anti-pH3 rabbit antibody 
(Santa Cruz Biotechnology, Inc.) for 1 h at RT, followed by three washes in 
PBS and incubation with an Alexa 488  –  conjugated secondary antibody 
before DAPI counterstaining and evaluation of mitotic index by ﬂ  uores-
cence microscopy. 
  DNA ﬁ  ber assay 
  We measured the efﬁ  ciency of replication recovery using the DNA ﬁ  ber as-
say. First, DNA replication sites were labeled with 25   μ  M IdU (30 min), then 
cells were treated with 2 mM HU for 6 or 14 h to induce replication fork 
stalling. After treatment, cells were washed twice with PBS and incubated for 
60 min in fresh medium with 100   μ  M CldU. To visualize sites of DNA repli-
cation, we prepared chromosomal DNA ﬁ  bers on glass slides as described 
previously (  Seiler et al., 2007  ). DNA ﬁ   bers were analyzed through an 
epiﬂ  uorescence microscope (Leica) equipped with a charge-coupled device 
camera. Images were acquired as grayscale ﬁ  les using Metaview software 
and then processed using Photoshop. Tracks containing IdU were pseudo-
colored in red and represent all sites of DNA replication that were active 
before stalling. Tracks containing CldU were pseudo-colored in green and 
represent sites where DNA synthesis is recovered after HU removal. When 
CldU incorporation took place at previously stalled forks that remain active 
during the HU block, green tracks will start at sites of stalling with a certain 
degree of colocalization because of the limitation of the technique. 
  Signiﬁ  cance of the difference between the means from the indicated 
genotypes was determined by a Student  ’  s   t   test. 
  Online supplemental material 
  Fig. S1 shows formation of DSBs in WS lymphoblasts. Fig. S2 shows that 
MUS81 down-regulation does not interfere with the inhibition of DNA 
previously (  Pichierri et al., 2001  ), cells were ﬁ  xed in 2% PFA/PBS for 
20 min and permeabilized using 0.25% Triton X-100 for 10 min before 
being incubated with 5% normal serum/PBS for 60 min. After blocking, 
coverslips were incubated for 2 h with rabbit polyclonal anti  –      -H2AX anti-
body (1:1,000; Millipore) alone or in combination with either Alexa 488  –
  conjugated anti-BrdU (1:500; Invitrogen) or sheep polyclonal anti  –  CENP-F 
(1:1,000; gift of S. Taylor, University of Manchester, Manchester, England, 
UK). Coverslips were then washed extensively, incubated with ﬂ  uorescent 
secondary antibodies before being counterstained with DAPI, and ob-
served with a 60  ×   oil-immersion objective using an epiﬂ  uorescence micro-
scope (Leica) equipped with a charge-coupled device camera (Photometrics). 
Images were acquired as grayscale ﬁ  les using Metaview software (MDS 
Analytical Technologies) and processed using Photoshop (Adobe) to adjust 
contrast and brightness of the image. For each time point, at least 200 nu-
clei were examined, and foci were scored at a 60  ×   magniﬁ  cation. Only 
nuclei showing more than ﬁ  ve bright foci were considered to be positive. 
Parallel samples incubated with either the appropriate normal serum or 
only with the secondary antibody conﬁ  rmed that the observed ﬂ  uorescence 
pattern was not attributable to artifacts. 
  Western blot and chromatin fractionation 
  10 
6   cells were trypsinized and collected by low-speed centrifugation, 
washed in PBS, and lysed in 300   μ  l of 2  ×   electrophoresis sample buffer. 
One tenth of the lysate was loaded on 4  –  12% NuPage/MOPS gels (Invitro-
gen). Alternatively, proteins were separated on standard 6% or 8% SDS-
PAGE. Blots were incubated separately (overnight at 4  °  C) with primary 
antibodies against MUS81 (1:2,000; AbCam), WRN (1:300; Santa Cruz 
Biotechnology, Inc.),     -tubulin (1:20,000; Sigma-Aldrich), pS345CHK1 
(1:1,000; Cell Signaling Technology), PCNA (1:2,000; Santa Cruz Biotech-
nology, Inc.), CHK1, RAD52 (1:500; Santa Cruz Biotechnology, Inc.), and 
RAD51 (1:1,000; EMD). Horseradish peroxidase  –  conjugated goat specie-
speciﬁ  c secondary antibodies (Santa Cruz Biotechnology, Inc.) were used at 
a dilution of 1:2,000, and visualization of the signal was accomplished us-
ing Super Signal West Dura substrate (Thermo Fisher Scientiﬁ  c). 
  For the analysis of the PCNA, MUS81, RAD52, and RAD51 distribu-
tion in the chromatin fraction, 3   ×   10 
6   cells were processed as described 
previously (  Pichierri et al., 2004  ). Chromatin-bound proteins were analyzed 
by Western blotting. Western blotting using an anti-H3 histone antibody 
(1:2,000; Millipore) or anti-ORC2 antibody (1:1,000; Santa Cruz Biotech-
nology, Inc.) served as a loading control for the chromatin fractions. 
  Quantiﬁ   cation was performed on scanned images of blots using 
ImageJ software, and values shown on the graphs represent a percentage 
compared with the matched untreated control normalized against the pro-
tein content evaluated through histone H3 or ORC2 immunoblotting. 
  Flow cytometry analysis of PCNA association with chromatin 
  To analyze PCNA release from chromatin after treatments, cells were han-
dled and analyzed by ﬂ  ow cytometry, as described previously (  Scovassi 
and Prosperi, 2006  ). The amount of chromatin-associated PCNA was de-
termined from the mean ﬂ  uorescent intensity of the S-phase cells after gat-
ing as described in   Fig. 2  . 
  Evaluation of cellular viability and chromosomal damage 
  The sensitivity of cells to increasing doses of HU was evaluated by clono-
genic survival. 24 h after transfection with the indicated siRNAs, SV40-
transformed ﬁ  broblasts or HeLa cells were plated onto 60-mm dishes and 
cultured for an additional 24 h before exposure to HU for 14 h. After treat-
ment, cells were grown for additional 7 d and ﬁ  xed, then colony numbers 
were counted. Survival was expressed as a percentage of the number of 
clones in the untreated cultures, and values represent means   ±   SE from trip-
licate experiments. The analysis of the spontaneous and induced SCEs was 
performed on metaphase cells after treatment with 2 mM HU for 12 h, as 
described previously (  Pichierri et al., 2000  ,   2004  ). When RNAi-treated 
cells were used, treatments were performed 48 h after transfection with 
siRNAs. A minimum of 200 metaphase cells was scored for each experi-
mental point by two independent investigators. 
  Statistical analysis 
  All the reported data were evaluated pairwise comparing WS and wild-
type cells. Data, with the exception of PCNA release from chromatin and 
chromosomal damage, are presented as mean   ±   SE and were derived 
from at least three repeated experiments. Data from PCNA release from 
chromatin and chromosomal damage are representative of at least dupli-
cate experiments giving consistent results, and were evaluated using the 
analysis of variance test or Student  ’  s   t   test. 251 ALTERNATIVE FORK RECOVERY IN WS CELLS   • Franchitto et al. 
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